Journal article Open Access

Molecular targets for AIDS therapy

Mitsuya, H.; Yarchoan, R.; Broder, S.

JSON-LD ( Export

  "description": "The development of antiretroviral therapy against acquired immunodeficiency syndrome (AIDS) has been an intense research effort since the discovery of the causative agent, human immunodeficiency virus (HIV). A large array of drugs and biologic substances can inhibit HIV replication in vitro. Nucleoside analogs--particularly those belonging to the dideoxynucleoside family--can inhibit reverse transcriptase after anabolic phosphorylation. 3'-Azido-2',3'-dideoxythymidine (AZT) was the first such drug tested in individuals with AIDS, and considerable knowledge of structure-activity relations has emerged for this class of drugs. However, virtually every step in the replication of HIV could serve as a target for a new therapeutic intervention. In the future, non-nucleoside-type drugs will likely become more important in the experimental therapy of AIDS, and antiretroviral therapy will exert major effects against the morbidity and mortality caused by HIV.", 
  "license": "", 
  "creator": [
      "@type": "Person", 
      "name": "Mitsuya, H."
      "@type": "Person", 
      "name": "Yarchoan, R."
      "@type": "Person", 
      "name": "Broder, S."
  "headline": "Molecular targets for AIDS therapy", 
  "image": "", 
  "datePublished": "1990-09-28", 
  "url": "", 
  "@context": "", 
  "identifier": "", 
  "@id": "", 
  "@type": "ScholarlyArticle", 
  "name": "Molecular targets for AIDS therapy"
Views 482
Downloads 291
Data volume 887.0 MB
Unique views 460
Unique downloads 276


Cite as